RLAY
Price
$2.49
Change
+$0.02 (+0.81%)
Updated
Apr 2 closing price
Capitalization
422.11M
28 days until earnings call
XNCR
Price
$9.82
Change
+$0.13 (+1.34%)
Updated
Apr 2 closing price
Capitalization
691.94M
35 days until earnings call
Ad is loading...

RLAY vs XNCR

Header iconRLAY vs XNCR Comparison
Open Charts RLAY vs XNCRBanner chart's image
Relay Therapeutics
Price$2.49
Change+$0.02 (+0.81%)
Volume$2.11M
Capitalization422.11M
Xencor
Price$9.82
Change+$0.13 (+1.34%)
Volume$765.39K
Capitalization691.94M
RLAY vs XNCR Comparison Chart
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. XNCR commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Hold and XNCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (RLAY: $2.47 vs. XNCR: $9.82)
Brand notoriety: RLAY and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 130% vs. XNCR: 116%
Market capitalization -- RLAY: $422.11M vs. XNCR: $691.94M
RLAY [@Biotechnology] is valued at $422.11M. XNCR’s [@Biotechnology] market capitalization is $691.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 4 bearish.
  • XNCR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than RLAY.

Price Growth

RLAY (@Biotechnology) experienced а -16.55% price change this week, while XNCR (@Biotechnology) price change was -11.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

RLAY is expected to report earnings on May 01, 2025.

XNCR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($692M) has a higher market cap than RLAY($422M). RLAY YTD gains are higher at: -39.563 vs. XNCR (-57.267). XNCR has higher annual earnings (EBITDA): -186.17M vs. RLAY (-380.21M). RLAY has more cash in the bank: 781M vs. XNCR (498M). RLAY has less debt than XNCR: RLAY (48.5M) vs XNCR (232M). XNCR has higher revenues than RLAY: XNCR (110M) vs RLAY (10M).
RLAYXNCRRLAY / XNCR
Capitalization422M692M61%
EBITDA-380.21M-186.17M204%
Gain YTD-39.563-57.26769%
P/E RatioN/AN/A-
Revenue10M110M9%
Total Cash781M498M157%
Total Debt48.5M232M21%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 22 days ago
80%
Bullish Trend 14 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAGCX44.170.33
+0.75%
Janus Henderson Glb Tech and Innovt C
PLXGX20.21N/A
N/A
Virtus KAR Capital Growth I
GTSAX26.12N/A
N/A
Invesco Small Cap Growth A
CUHCX10.07N/A
N/A
Victory US 500 Enh Vol Wtd Idx C
TVRCX14.21N/A
N/A
NAA Allocation Fund C

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+0.81%
XNCR - RLAY
47%
Loosely correlated
+1.34%
FHTX - RLAY
44%
Loosely correlated
+1.33%
VCYT - RLAY
44%
Loosely correlated
+1.93%
BCYC - RLAY
44%
Loosely correlated
+2.55%
AXON - RLAY
42%
Loosely correlated
+3.18%
More